Beijing Konruns Pharmaceutical Co Ltd (603590) — Capital Reinvestment Ratio
Beijing Konruns Pharmaceutical Co Ltd (603590) has a Capital Reinvestment Ratio of 0.18x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥96.44 Million) in capital expenditures (CN¥17.27 Million). See Beijing Konruns Pharmaceutical Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Beijing Konruns Pharmaceutical Co Ltd Capital Reinvestment Ratio (2013–2025)
This chart tracks Beijing Konruns Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 13 annual periods.
Annual Capital Reinvestment Ratio for Beijing Konruns Pharmaceutical Co Ltd (2013–2025)
Year-by-year Capital Reinvestment Ratio for Beijing Konruns Pharmaceutical Co Ltd from 2013 to 2025. For live market cap and broader valuation context, see Beijing Konruns Pharmaceutical Co Ltd market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.46x | CN¥115.68 Million | CN¥53.45 Million | ▼ -23.5% |
| 2024 | 0.60x | CN¥172.25 Million | CN¥104.02 Million | ▲ +19.3% |
| 2023 | 0.51x | CN¥199.35 Million | CN¥100.91 Million | ▼ -37.1% |
| 2022 | 0.80x | CN¥119.69 Million | CN¥96.31 Million | ▼ -65.3% |
| 2021 | 2.32x | CN¥70.91 Million | CN¥164.65 Million | ▲ +169.2% |
| 2020 | 0.86x | CN¥58.41 Million | CN¥50.37 Million | ▲ +1096.5% |
| 2019 | 0.07x | CN¥262.00 Million | CN¥18.89 Million | ▲ +12.6% |
| 2018 | 0.06x | CN¥263.11 Million | CN¥16.85 Million | ▼ -48.7% |
| 2017 | 0.12x | CN¥270.49 Million | CN¥33.73 Million | ▼ -89.7% |
| 2016 | 1.21x | CN¥148.26 Million | CN¥178.67 Million | ▲ +412.6% |
| 2015 | 0.24x | CN¥191.80 Million | CN¥45.09 Million | ▼ -10.0% |
| 2014 | 0.26x | CN¥130.98 Million | CN¥34.20 Million | ▼ -26.5% |
| 2013 | 0.36x | CN¥163.72 Million | CN¥58.17 Million | — |